XML 1096 R93.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shares and Stockholders' Equity (Details) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Restatement Adjustment [Member]
Accounting Standards Update 2010-26 [Member]
Dec. 31, 2012
Unrealized Gain (Loss) on AFS Securities [Member]
Dec. 31, 2011
Unrealized Gain (Loss) on AFS Securities [Member]
Dec. 31, 2010
Unrealized Gain (Loss) on AFS Securities [Member]
Dec. 31, 2009
Unrealized Gain (Loss) on AFS Securities [Member]
Scenario, Previously Reported [Member]
Dec. 31, 2009
Unrealized Gain (Loss) on AFS Securities [Member]
Restatement Adjustment [Member]
Accounting Standards Update 2010-26 [Member]
Dec. 31, 2009
Unrealized Gain (Loss) on AFS Securities [Member]
Restatement Adjustment [Member]
Accounting Standards Update 2009-17 [Member]
Dec. 31, 2012
Unrealized Other Than Temporary Impairment on Available For Sale Securities [Member]
Dec. 31, 2011
Unrealized Other Than Temporary Impairment on Available For Sale Securities [Member]
Dec. 31, 2010
Unrealized Other Than Temporary Impairment on Available For Sale Securities [Member]
Dec. 31, 2009
Unrealized Other Than Temporary Impairment on Available For Sale Securities [Member]
Scenario, Previously Reported [Member]
Dec. 31, 2009
Unrealized Other Than Temporary Impairment on Available For Sale Securities [Member]
Restatement Adjustment [Member]
Accounting Standards Update 2010-26 [Member]
Dec. 31, 2012
Unrealized Gain (Loss) on Derivative Instruments [Member]
Dec. 31, 2011
Unrealized Gain (Loss) on Derivative Instruments [Member]
Dec. 31, 2010
Unrealized Gain (Loss) on Derivative Instruments [Member]
Dec. 31, 2009
Unrealized Gain (Loss) on Derivative Instruments [Member]
Scenario, Previously Reported [Member]
Dec. 31, 2009
Unrealized Gain (Loss) on Derivative Instruments [Member]
Restatement Adjustment [Member]
Accounting Standards Update 2010-26 [Member]
Dec. 31, 2012
Foreign Currency Translation Adjustment [Member]
Dec. 31, 2011
Foreign Currency Translation Adjustment [Member]
Dec. 31, 2010
Foreign Currency Translation Adjustment [Member]
Dec. 31, 2012
Funded Status of Employee Benefit Plans [Member]
Dec. 31, 2011
Funded Status of Employee Benefit Plans [Member]
Dec. 31, 2010
Funded Status of Employee Benefit Plans [Member]
Dec. 31, 2012
Common stock warrant [Member]
Dec. 31, 2012
Series A Preferred Stock [Member]
Dec. 31, 2011
Series A Preferred Stock [Member]
Dec. 31, 2010
Series A Preferred Stock [Member]
Dec. 31, 2012
Series B Preferred Stock [Member]
Dec. 31, 2011
Series B Preferred Stock [Member]
Dec. 31, 2010
Series B Preferred Stock [Member]
Dec. 31, 2012
Common stock [Member]
Dec. 31, 2011
Common stock [Member]
Dec. 31, 2010
Common stock [Member]
Changes in preferred and common stock (number of shares) [Line Items]                                                                        
Balance as of beginning-of-year (in shares)                                                       10,072 10,914 11,497 0 0 950,000 291,319,222 315,718,554 302,223,281
Stock issued (in shares)                                                                   0 0 14,137,615
Conversion of convertible preferred stock (in shares)                                                       (540) (842) (583)       8,640 13,472 9,328
Issuance (redemption) of Series B preferred stock (in shares)                                                             0 0 (950,000)      
Stock compensation/issued for benefit plans (in shares)                                                                   542,125 248,553 414,712
Retirement/cancellation of shares (in shares)                                                                   (20,467,401) (24,661,357) (1,066,382)
Balance as of end-of-year (in shares)                                                       9,532 10,072 10,914 0 0 0 271,402,586 291,319,222 315,718,554
Common stock as of end-of-year:                                                                        
Assuming conversion of preferred stock (in shares) 271,555,098 291,480,374 315,893,178                                                                  
Diluted basis (in shares) 279,087,588 298,225,244 324,043,137                                                                  
Series B Preferred Stock Issuance and Redemption [Abstract]                                                                        
Outstanding warrant to purchase common stock (in shares)                                                     10,150,292                  
Exercise price of warrant (in dollars per share)                                                     $ 10.72                  
Reconciliation of the denominator (number of shares) in the calculations of basic and diluted earnings (loss) per common share Table                                                                        
Weighted-average shares, as used in basic calculation (in shares) 280,648,391 307,216,181 310,005,264                                                                  
Shares to cover exercise of outstanding warrants (in shares) 10,150,212 10,150,292 12,260,236                                                                  
Shares to cover conversion of preferred stock (in shares) 153,749 173,289 178,720                                                                  
Shares to cover non-vested stock (in shares) 1,153,178 813,905 616,314                                                                  
Average stock options outstanding during the year (in shares) 570,180 636,989 707,704                                                                  
Assumed acquisition of shares with assumed proceeds from exercising outstanding warrants (in shares) (4,685,901) (4,658,020) (5,148,473)                                                                  
Assumed acquisition of shares with assumed proceeds and benefits from exercising stock options (at average market price for the year) (in shares) (394,241) (427,425) (464,813)                                                                  
Shares repurchaseable from measured but unrecognized stock option expense (in shares) (4,723) (65,882) (139,673)                                                                  
Average deferred compensation shares (in shares) 0 1,110,722 1,198,468                                                                  
Weighted-average shares, as used in diluted calculation (in shares) 287,590,845 314,950,051 319,213,747                                                                  
Deferred compensation plan mark to market adjustment   5,000,000 2,000,000                                                                  
Components and changes in accumulated Other Comprehensive Income [Line Items]                                                                        
Balance as of beginning-of-year       3,000,000 2,947,000,000 1,176,000,000   49,000,000 2,000,000 181,000,000 (109,000,000) (134,000,000)   (115,000,000) (5,000,000) 119,000,000 (11,000,000)   11,000,000 3,000,000 1,000,000 1,000,000 3,000,000 (278,000,000) (181,000,000) (210,000,000)                    
Unrealized holding gains (losses) arising during the year         2,691,000,000 3,414,000,000 2,528,000,000                                                          
Change in foreign currency exchange rate adjustment         14,000,000 (5,000,000) (6,000,000)                 (12,000,000) 7,000,000 4,000,000                                    
Change in DAC, VOBA, DSI and other contract holder funds         (1,233,000,000) (797,000,000) (1,038,000,000)                 15,000,000 0 0                                    
Income tax benefit (expense)         (480,000,000) (932,000,000) (535,000,000)                                                          
Less: Reclassification adjustment for gains (losses) included in net income (loss)         (194,000,000) (129,000,000) (135,000,000)                                                          
Less: Reclassification adjustment for gains (losses) on derivatives included in net income (loss)         0 0 135,000,000                                                          
Less: Associated amortization of DAC, VOBA, DSI, and DFEL         (2,000,000) (11,000,000) 8,000,000                                                          
Less: Income tax benefit (expense)         69,000,000 49,000,000 (3,000,000)                                                          
Increases attributable to: Gross OTTI recognized in OCI during the year                     (121,000,000) (58,000,000) (97,000,000)                                              
Increases attributable to: Change in DAC, VOBA, DSI and DFEL                     15,000,000 13,000,000 10,000,000                                              
Increases attributable to: Income tax benefit (expense)                     36,000,000 16,000,000 30,000,000                                              
Decreases attributable to: Sales, maturities or other settlements of AFS Securities                     129,000,000 103,000,000 87,000,000                                              
Decreases attributable to: Change in DAC, VOBA, DSI, and DFEL                     (18,000,000) (20,000,000) (20,000,000)                                              
Decreases attributable to: Income tax benefit (expense)                     (39,000,000) (29,000,000) (24,000,000)                                              
Unrealized holding gains (losses) arising during the year                               55,000,000 184,000,000 (27,000,000)                                    
Change in DAC, VOBA, DSI and DFEL                               15,000,000 0 0                                    
Income tax benefit (expense)                               (21,000,000) (67,000,000) 7,000,000                                    
Less: Reclassification adjustment for gains (losses) included in net income (loss)                               (15,000,000) (10,000,000) 14,000,000                                    
Less: Associated amortization of DAC, VOBA, DSI and DFEL                               4,000,000 1,000,000 0                                    
Less: Income tax benefit (expense)                               4,000,000 3,000,000 (5,000,000)                                    
Foreign currency translation adjustment arising during the year                                         (5,000,000) 0 (3,000,000)                          
Income tax benefit (expense)                                         0 0 1,000,000                          
Adjustment arising during the year                                               2,000,000 (149,000,000) 45,000,000                    
Income tax benefit (expense)                                               (34,000,000) 52,000,000 (16,000,000)                    
Balance as of end-of-year       $ 3,000,000 $ 4,066,000,000 $ 2,947,000,000 $ 1,176,000,000 $ 49,000,000 $ 2,000,000 $ 181,000,000 $ (107,000,000) $ (109,000,000) $ (134,000,000) $ (115,000,000) $ (5,000,000) $ 163,000,000 $ 119,000,000 $ (11,000,000) $ 11,000,000 $ 3,000,000 $ (4,000,000) $ 1,000,000 $ 1,000,000 $ (310,000,000) $ (278,000,000) $ (181,000,000)